Dr Reddy\'s Labs
May 25, 2012 at 11:30 | Source: CNBC-TV18
May 22, 2012 at 12:51 | Source: BizTech2.com
May 18, 2012 at 11:49 | Source: Moneycontrol.com
May 17, 2012 at 08:28 | Source: CNBC-TV18
May 16, 2012 at 12:56 | Source: Moneycontrol.com
May 12, 2012 at 17:58 | Source: Moneycontrol.com
Interact & exchange stock tips & market info »
Related News »
Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched over-the-counter (OTC) Lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy’s ANDA approval by the United States Food & Drug ...
May 21, 2012 at 10:46 | Source: StreetInsider.com
Dr. Reddy’s Laboratories (NYSE: RDY) has launched CLOPIDOGREL TABLETS, USP 75 mg & 300 mg, a bioequivalent generic version of Sanofi's (NYSE: SNY) PLAVIX®, in the U.S. market on May 18, 2012. The ANDAs for Clopidogrel Tablets USP, 75 mg & 300 mg are ...
May 18, 2012 at 10:43 | Source: StreetInsider.com
NEW YORK (AP) — Generic drugmaker Dr. Reddy's Laboratories Ltd. said Friday that no its profit grew 2 percent in the fiscal fourth quarter on greater revenue from its major markets. The Hyderabad, India, company said its profit rose to 3.43 billion ...
May 25, 2012 at 23:56 | Source: YAHOO!
Results of Dr. Reddy's Labs (DRL) for Q4FY12 were lower than our expectations due to lower than expected sales growth & margin and impairment loss. The company reported sales growth of 32%YoY due to good growth across its global generics and ...
May 16, 2012 at 18:30 | Source: equitybulls.com
Dr Reddy's Laboratories disappointed the street as fourth quarter consolidated net profit rose lower-than-expected 2.5% year-on-year to Rs 342.70 crore. The pharma major had impairment loss on intangible assets of Rs 104 crore in the quarter.
May 11, 2012 at 09:03 | Source: MoneyControl.com
(RTTNews) - Dr. Reddy's Laboratories (RDY: News ) announced that it has launched Clopidogrel Tablets, USP75 mg & 300 mg, a bioequivalent generic version of PLAVIX, in the U.S. market on May 18, 2012. The ANDAs for Clopidogrel Tablets USP,75 mg & 300 mg are ...
May 18, 2012 at 05:35 | Source: RTT News
In the other space, Dr Reddys Laboratories was down 4.11% at USD 30.60, Sterlite was down 0.55% at USD 7.23 while Tata Motors was up 1.44% at USD 27.55.
May 12, 2012 at 05:06 | Source: MoneyControl.com
Generic drugmaker Dr. Reddy's Laboratories Ltd. said Friday that no its … Full Story »Dr. Reddy's Labs 4Q profit rises 2 percent
May 25, 2012 at 23:56 | Source: YAHOO!
With earnings upgrade, the current market price for the stock looks undervalued. JPMorgan has given a buy call for pharmaceutical major Dr Reddy's Labs. JPMorgan analysts believe that the pharmaceutical company will show better performance in local markets.
May 16, 2012 at 18:59 | Source: Top News India
The following are the GDR and ADR rates for May 28 in US dollars, with the difference vis-a-vis the previous level given as a percentage in brackets: Company: Price Percent chg Dr Reddy''s Labs (ADR) 30.26 (UNCH.) Gail (GDR) 36.25 (UNCH.) Grasim Industries ...
May 29, 2012 at 08:56 | Source: MSN India